Concord Medical Services Holdings Limited
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Jianyu Yang
- Full Time Employees
- 595
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- Tower A, Global Trade Center Beijing People's Republic of China 100013
- IPO Date
- Dec 11, 2009
- CIK
- 0001472072
- Website
- concordmedical.com
- Similar Companies
- Business
- Concord Medical Services Holdings Limited (NYSE: CCM) operates as a leading healthcare provider in China, specializing in cancer treatment and diagnostic services through its network of proton therapy centers and radiotherapy facilities. The company offers advanced cancer therapies including proton therapy using systems such as the ProBeam from Varian Medical Systems; intensity-modulated radiation therapy (IMRT); image-guided radiation therapy (IGRT); and stereotactic body radiation therapy (SBRT), along with comprehensive diagnostic imaging services encompassing CT, MRI, PET/CT, and ultrasound scans. Headquartered in Beijing, China, and founded in 1997, Concord Medical primarily serves patients across major Chinese cities including Beijing, Shanghai, Kunming, and Dalian, targeting oncology patients and healthcare institutions in the domestic market. In recent developments, the company has focused on expanding its proton therapy capabilities with the opening of new centers and partnerships for equipment installation, while navigating delisting risks from NYSE and potential privatization efforts amid challenging market conditions in the healthcare sector.
Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025
Concord Medical Schedules 2025 Annual Meeting of Shareholders
Ethic Inc. Sells 47,560 Shares of CCM Affordable Housing MBS ETF $OWNS
Top 2 Health Care Stocks That May Keep You Up At Night This Month
Canagold Resources adds to executive team to advance New Polaris
Investment Company CCM Starts a Position in KLA Corporation. Is the Stock a Buy?
Investment Company CCM Opened a Position in Oracle. Does This Mean the Stock Is a Buy?
Investment Company CCM Initiated a Position in AMD. Is the Stock a Buy?
Concord Medical Reports Financial Results for the First Half of 2025
Sun Valley Investments AG Announces Acquisition of Securities of Canagold Resources Inc.
Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma
Concord Healthcare Announces Official Release of the Proton Therapy Large Model
Concord Medical Files Annual Report on Form 20-F for Fiscal 2024
Concord Medical Announces Result of 2024 Annual General Meeting
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
Concord Medical Schedules 2024 Annual Meeting of Shareholders
Concord Medical Reports Financial Results for the First Half of 2024
Canagold Completes Resource Expansion Drilling Program at New Polaris with Additional Strong Mineralization Intercepts
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment